Letter to OHRP on Canakinumab (Ilaris)

View publication as PDF.

We hereby request that the Office for Human Research Protections (OHRP) promptly conduct a compliance oversight investigation of an ongoing research study that is entirely supported by the Department of Health and Human Services (HHS).

July 9, 2013, Response from the Office for Human Research Protections